We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
GlaxoSmithKline (GSK) has announced the reintroduction of Typherix® (Vi polysaccharide typhoid vaccine) and Hepatyrix® (hepatitis A and typhoid combined).
In 2011, GSK suspended the production of these vaccines due to manufacturing capacity constraints.
Vaccine orders can now be placed via the normal routes.
Enquiries to: GSK Customer Contact Team, Tel: 0808 100 9997
Vivotif® (oral typhoid vaccine) - Janssen-Cilag Ltd, currently there are no supply constraints on this product.
Epaxal® (hepatitis A vaccine) - Janssen-Cilag Ltd, currently there are no supply constraints on this product.
Enquiries to: MASTA, Customer services Tel:0113 238 7500
Typhim Vi® (Vi polysaccharide typhoid vaccine) - update to follow shortly.
Avaxim® (hepatitis A vaccine) - currently supply is restricted, however, Vaqta Adult® (hepatitis A vaccine) - is available to ensure continued supply of hepatitis A vaccine.
ViATIM® (hepatitis A/typhoid vaccine) - currently there are no supply constraints on this product.
Vaqta Paediatric® (hepatitis A vaccine) - currently there are no constraints on supply of this product.
Enquiries to: Sanofi Pasteur MSD Customer Operations team, Tel: 0800 085 5511.
